SPINT2 and neoplasm: In addition, discovery of a novel interaction partners including Kunitz-type protease inhibitor SPINT2, pointed to the novel mechanism of tumor suppressor role of COMT in ER dependent breast cancer through the interplay with MET signaling pathway.